U.S. Specialty Stores Stock News

NYSE:GM
NYSE:GMAuto

GM Recall And Supplier Strike Risks Versus Valuation And Momentum

General Motors (NYSE:GM) is recalling nearly 7,000 Cadillac, Chevrolet, and GMC vehicles due to airbag defects that may eject metal fragments. A separate strike involving nearly 1,000 workers at a key supplier is putting pickup truck production at risk, with potential disruption at major assembly plants. Both developments present operational and reputational risks that are relevant for GM shareholders and other stakeholders. For readers tracking NYSE:GM, this combination of airbag recalls...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance’s Australian Amtagvi Nod Adds Test For Valuation Upside

Iovance Biotherapeutics received conditional approval from Australia's TGA for Amtagvi, its cell therapy for advanced melanoma. This is Amtagvi's third marketing authorization and extends access to a market with one of the highest melanoma rates globally. The news adds a fresh angle for Iovance Biotherapeutics (NasdaqGM:IOVA), which has recently drawn attention around US developments but less so around its international reach. The stock trades at $3.79 and has gained 50.4% year to date and...
NasdaqGS:SMCI
NasdaqGS:SMCITech

Super Micro Computer (SMCI) Valuation Check After New AI Platforms And US$2b Gorilla Technology Deal

Super Micro Computer (SMCI) is back in focus after unveiling its AMD Helios rack scale AI platform, new Arm AGI CPU based systems at Computex, and a US$2b AI infrastructure deal with Gorilla Technology. See our latest analysis for Super Micro Computer. Those product launches and the US$2b Gorilla Technology deal come after a sharp run in the stock, with a 68.52% 1‑month share price return and a very large 5‑year total shareholder return of 1,188.11%. This suggests momentum has been strong but...
NYSE:A
NYSE:ALife Sciences

A Look At Agilent Technologies (A) Valuation As FDA Approval AI Deal And Earnings Update Draw Focus

Agilent Technologies (A) stock is back in focus after a packed stretch of news, including expanded FDA approval for its PD-L1 diagnostic, a new artificial intelligence collaboration with OpenAI and Boston Consulting Group, and stronger than expected quarterly results with raised guidance. See our latest analysis for Agilent Technologies. The recent AI collaboration and product launches have coincided with a 17.73% 1 month share price return and a 20.25% 3 month share price return. The 1 year...
NYSE:TDG
NYSE:TDGAerospace & Defense

A Look At TransDigm Group (TDG) Valuation After Recent Share Price Pullback And Long Term Gains

Return profile and recent share performance TransDigm Group (TDG) has drawn attention after a mixed stretch for the stock, with short term returns moving differently from its longer multi year track record that investors often watch closely. Over the past month, the stock gained about 3%, while it declined roughly 5% over the past 3 months and is down about 9% year to date. Over the past year, the total return also declined about 9%. In comparison, the 3 year and 5 year total returns are both...
NasdaqCM:ZENA
NasdaqCM:ZENASoftware

ZenaTech Expands Into Defense Tech As Shares Trade Well Below Target

ZenaTech (NasdaqCM:ZENA) is moving into the defense technology sector with counter unmanned aerial systems interceptor drones. The company is expanding its operations through acquisitions of land survey and legacy service businesses. ZenaTech has acquired a stake in Plurilock Security and is pursuing collaborations and investment opportunities with U.S. defense agencies. ZenaTech is shifting its focus beyond its core Drone as a Service operations as the stock trades around $1.52. The share...
NYSE:ELV
NYSE:ELVHealthcare

How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients

In late May 2026, Elevance Health Inc. highlighted its Get Connected for Health program and CareBridge services, which provide free smartphones, tablets, connectivity, and multilingual virtual care to help underserved members overcome the digital divide and better manage their healthcare. By embedding digital access directly into care delivery for Medicaid, Dual-Special Needs, and long-term support populations, Elevance Health is tying its growth in value-based services to a broader push for...
NYSE:CAT
NYSE:CATMachinery

Is It Too Late To Consider Caterpillar (CAT) After 172% One-Year Surge?

If you are wondering whether Caterpillar at US$940.48 is still offering value, the key is understanding what the current price actually implies about the business. The stock has delivered returns of 5.9% over the past week, 4.0% over the past month, 57.2% year to date and 172.4% over the last year, which has put valuation squarely in the spotlight for many investors. Recent coverage has focused on Caterpillar as a major player in heavy equipment and capital goods, with attention on how its...
NasdaqGS:LULU
NasdaqGS:LULULuxury

Lululemon Reset Deepens As Outlook Cut Tests New Leadership And Valuation

Lululemon Athletica (NasdaqGS:LULU) cut its full-year revenue outlook and issued weaker guidance for the upcoming quarter. The company updated its outlook as it works through a broad reset of its plans following a recent board shakeup and proxy dispute resolution. The new guidance points to pressure in North America and highlights execution risks for the refreshed leadership team. Lululemon Athletica, known for its premium athletic apparel and accessories, now sits at a crossroads as it...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Is Coupang’s Rising Fortune 500 Rank and AI Logistics Push Altering The Investment Case For Coupang (CPNG)?

Coupang was recently named to the Fortune 500 for the fourth consecutive year, climbing 10 places to No. 132 on the back of its global fulfillment and logistics expansion. The company’s push into AI-enhanced logistics and new markets such as Taiwan suggests its logistics network is increasingly becoming a global infrastructure platform. We’ll now examine how Coupang’s higher Fortune 500 ranking and AI‑driven global logistics expansion could influence its broader investment narrative. Invest...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

Did PepsiCo’s (PEP) New PopCorners Protein Launch Just Redefine Its Wellness-Focused Investment Story?

In late May 2026, PepsiCo expanded its better-for-you snack lineup by launching PopCorners Protein, a popped, never-fried chip offering 9 grams of protein per serving in three flavors and rolling out nationwide from July after an initial release in select retailers. This move adds another health-oriented, higher-protein option alongside recent PepsiCo launches in protein, fiber, and prebiotic products, underlining a broader push to align its snack and beverage portfolio with wellness-focused...
NYSE:CPRI
NYSE:CPRILuxury

Capri Holdings (CPRI) Valuation Check After Return To Profit And Completed Share Buyback

Capri Holdings (CPRI) reported fourth quarter and full year results on May 27, with full year net income of US$137 million compared with a large loss previously, alongside lower sales and a completed US$79 million buyback. See our latest analysis for Capri Holdings. The earnings swing back to profit and completion of the US$79 million buyback come as Capri Holdings trades at US$18.83, with a 1-day share price return of 2.11%, a year-to-date share price decline of 22.80%, and a 1-year total...
NYSE:IQV
NYSE:IQVLife Sciences

How IQVIA’s €950 Million Debt Refinancing and 2026 Outlook Update Will Impact IQVIA Holdings (IQV) Investors

IQVIA Holdings’ subsidiary recently announced a €950 million senior notes offering due 2033 to refinance existing debt and cover related fees, with the notes privately placed under Rule 144A and Regulation S. Alongside this refinancing move, IQVIA raised its adjusted earnings outlook for 2026, underlining management’s confidence in the company’s underlying operations and balance sheet flexibility. Next, we’ll assess how IQVIA’s €950 million debt refinancing reshapes its investment narrative,...
NasdaqGS:CMPS
NasdaqGS:CMPSBiotechs

Assessing COMPASS Pathways (CMPS) Valuation After Positive Phase 3 COMP360 Trial Milestone

COMPASS Pathways (CMPS) is in focus after reporting that its pivotal Phase 3 COMP005 trial of COMP360 for treatment resistant depression met its primary endpoint, with statistically significant efficacy and a safety profile consistent with earlier studies. See our latest analysis for COMPASS Pathways. The Phase 3 readout lands after a series of governance and capital markets updates, including new director appointments, fresh equity incentives for board members and a recent conference...
NasdaqCM:LWLG
NasdaqCM:LWLGElectronic

Lightwave Logic (LWLG) Valuation Check After Silicon Photonics Optimism And Recent Share Price Volatility

Nvidia CEO Jensen Huang’s upbeat comments on silicon photonics, highlighting companies such as Marvell Technology for major growth potential, have drawn fresh attention to Lightwave Logic (LWLG) and its recent share price swings. See our latest analysis for Lightwave Logic. The recent rally in sector sentiment following Huang’s silicon photonics remarks, combined with bargain hunting after the stock fell about 27% over the past 30 days, has kept Lightwave Logic’s short term share price...
NYSE:TMO
NYSE:TMOLife Sciences

Is It Time To Revisit Thermo Fisher Scientific (TMO) After Recent Share Price Swings?

If you are wondering whether Thermo Fisher Scientific at around US$482 per share looks like an opportunity or a stock to be cautious with, the key is understanding what you are actually paying for today. The stock has been mixed recently, with the share price down 1.1% over the last week, up 3.3% over the last month and up 21.4% over the last year. The return year to date is down 18.6%, and the three and five year returns are down 5.6% and up 5.1% respectively. Investors have been reacting...
NYSE:POST
NYSE:POSTFood

A Look At Post Holdings (POST) Valuation After Debt Concerns And Insider Selling Drive 52‑Week Low

Post Holdings hits 52-week low as debt, dividend policy and insider selling draw attention Post Holdings (POST) has hit a new 52-week low of $91.70, with investors focused on its high debt-to-equity ratio, lack of dividend yield, recent insider selling, and updated valuation metrics. See our latest analysis for Post Holdings. At a latest share price of $91.00, Post Holdings has declined over recent weeks, with a 1-month share price return of 12.37% down and a 1-year total shareholder return...
NYSE:SIG
NYSE:SIGSpecialty Retail

A Look At Signet Jewelers (SIG) Valuation After Earnings Beat Guidance Raise And Buyback Announcement

Signet Jewelers (SIG) has just delivered quarterly results that topped earnings forecasts, with steady comparable sales growth and double digit operating income improvement, while also raising full year sales and earnings guidance. See our latest analysis for Signet Jewelers. Despite the earnings beat and raised full year outlook, the stock has recently pulled back, with the 1 day share price return down 3%, even as the 1 year total shareholder return stands at 16% and 5 year total...
NYSE:LNG
NYSE:LNGOil and Gas

A Look At Cheniere Energy (LNG) Valuation As Sabine Pass Expansion Contract Targets Long Term LNG Demand

Bechtel contract puts Sabine Pass expansion in focus Cheniere Energy (LNG) has signed a US$4.69b contract with Bechtel for the first phase of its Sabine Pass LNG expansion, putting a sizable new capital project on investors’ radar. The agreement covers engineering, procurement, and construction for Train 7 and related infrastructure. Early work has already been authorized, and a final investment decision is targeted by early 2027. See our latest analysis for Cheniere Energy. At a share price...
NYSE:AROC
NYSE:AROCEnergy Services

Archrock (AROC) Is Down 5.9% After Q1 Miss But Reaffirmed 2026 EBITDA Guidance - Has The Bull Case Changed?

Archrock Inc. recently reported first-quarter 2026 results that fell short of analyst expectations on both earnings and revenues, with earnings flat year over year as higher SG&A costs weighed on performance. Despite the miss, Archrock reaffirmed its full-year 2026 adjusted EBITDA guidance, highlighting resilient growth in contract operations that helped offset a seasonally weaker aftermarket services segment. With earnings and revenues missing estimates but full-year guidance reaffirmed,...
NYSE:OSCR
NYSE:OSCRInsurance

Oscar Health CTO Shift Tests AI Execution And Investor Confidence

Oscar Health (NYSE:OSCR) co founder and former CTO Mario Schlosser is shifting into an advisory role focused on AI and digital health. The leadership change has raised questions among investors about product direction and continuity of Oscar's technology platform. Schlosser will remain on the Board and continue to shape Oscar's AI and digital health agenda. Oscar Health's stock recently closed at $20.50, with the move coinciding with a share price reaction and a return of down 6.8% over the...
NasdaqCM:WYFI
NasdaqCM:WYFIIT

WhiteFiber’s $160M AI Deal And Crypto Debt Shape Growth And Risk Profile

WhiteFiber (NasdaqCM: WYFI) has signed a five year, $160m AI compute infrastructure contract in the Paris region, using NVIDIA GPUs for an investment grade customer. The company has also arranged a $100m delayed draw term loan with Bit Digital, secured by Ethereum backed assets. Both agreements are structured with prepayments and project specific funding intended to limit balance sheet exposure as service begins. For investors tracking WhiteFiber at a share price of $28.03, the stock has...
NasdaqGM:ODD
NasdaqGM:ODDPersonal Products

Assessing Oddity Tech (ODD) Valuation After Weak Earnings And Steep Revenue Guidance Cut

Why Oddity Tech’s latest earnings and outlook matter for investors Oddity Tech (ODD) recently reported a swing from profit to net loss alongside lower first quarter sales, and guided to a 25% to 30% year-over-year net revenue decline for the second quarter. This combination of weaker recent results and cautious guidance has sharpened investor focus on Oddity Tech’s growth profile, profitability path, and how the stock’s sharp pullback over the past month and past 3 months fits into the...
NasdaqGS:UCTT
NasdaqGS:UCTTSemiconductor

The Bull Case For Ultra Clean Holdings (UCTT) Could Change Following AI‑Driven Demand For Chip Equipment

In the past week, Ultra Clean Holdings reported stronger demand for leading-edge foundry logic, high‑bandwidth memory, and advanced packaging tied to AI workloads, supported by increased wafer fab equipment spending and higher wafer starts at major semiconductor customers. An interesting angle for investors is how this rising AI‑related equipment demand coincides with expectations for significant year‑over‑year earnings improvement, reinforcing a more optimistic view of Ultra Clean’s...